文献速递脑血管病外科神经重症

慢性硬膜下血肿膜切除术的Meta分析

Membranectomy in Chronic Subdural Hematoma: Meta-Analysis.
PubMed 文献 · World Neurosurg · 2017-05-13

该Meta分析检索PubMed、Ovid和Cochrane数据库至2016年12月,纳入17项研究共5369例患者,评估慢性硬膜下血肿行开颅膜切除术的结局。汇总平均死亡率为3.7%、并发症率为6.9%、复发率为7.6%,作者认为该结果与文献中钻孔或开颅未行膜切除术的死亡率5%、并发症率3%-12%和复发率10%-21%具有可比性。

要点

  • 慢性硬膜下血肿行开颅膜切除术的汇总平均死亡率为3.7%。
  • 汇总平均并发症率为6.9%,复发率为7.6%。
  • 作者认为该结果与文献中钻孔或开颅未行膜切除术的结局具有可比性。

核心结论

  • 慢性硬膜下血肿膜切除术的临床数据仅限于单机构分析,复发率和随访时间存在相当大的变异。
  • 本Meta分析报告的死亡率、并发症率和复发率与文献中钻孔或开颅未行膜切除术的死亡率5%、并发症率3%-12%和复发率10%-21%具有可比性。

研究设计与样本

  • 研究为Meta分析,检索PubMed、Ovid和Cochrane数据库自建库至2016年12月的英文文献。
  • 检索词为「subdural hematoma」或「chronic subdural hematoma」与「membrane」或「membranectomy」。
  • 共检索到301篇文章,最终纳入17篇文献,共5369例患者。
  • 采用随机效应模型计算所有结局的汇总估计值和置信区间。

主要发现

  • 平均随访时间范围为1-30.8个月。
  • 汇总平均死亡率为3.7%(95%CI 2%-5.4%;P < 0.001)。
  • 汇总平均并发症率为6.9%(95%CI 2.1%-11.6%;P = 0.004)。
  • 汇总平均复发率为7.6%(95%CI 5%-10.2%;P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 慢性硬膜下血肿膜切除术的临床数据仅限于单机构分析,复发率和随访时间存在相当大的变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Initial management strategies of chronic subdural hematoma (cSDH) are controversial and range from bedside twist-drill or burr-hole drainage to craniotomy with membranectomy (CWM). We aim to 1) perform a meta-analysis of the available data on the outcomes of CWM for treatment of cSDH in published English-language literature and 2) evaluate collective outcomes of CWM with respect to morbidity, mortality, and recurrence rates. METHODS: A search of English-language literature performed in PubMed, Ovid, and Cochrane databases using key words ("subdural hematoma" or "chronic subdural hematoma") and ("membrane" or "membranectomy") from inception to December 2016 was conducted. Studies reporting outcomes of CWM in cSDH were included. Mortality, morbidity, follow-up duration, and recurrence rate data were extracted and analyzed. Pooled estimates and confidence intervals (CIs) were calculated for all outcomes using a random-effects model. RESULTS: Of 301 articles found, 17 articles containing 5369 patients met our eligibility criteria. Mean follow-up duration ranged from 1-30.8 months. Collective mean mortality and morbidity rates were 3.7% and 6.9%, respectively (95% CI 2-5.4% and 2.1-11.6%; P < 0.001 and P = 0.004). The collective mean recurrence rate was 7.6% (95% CI: 5%-10.2%; P < 0.001). CONCLUSIONS: Clinical data on outcomes of CWM in cSDH are limited to single institutional analyses, with considerable variation in recurrence rates and follow-up time. The rates we reported are comparable with the 5% mortality and 3%-12% morbidity rates and lower than the 10%-21% recurrence rate in the literature for burr holes or craniotomy without membranectomy. This meta-analysis provides an in-depth analysis of available data and reviews reported outcomes.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sahyouni R, Mahboubi H, Tran P, et al. Membranectomy in Chronic Subdural Hematoma: Meta-Analysis. World Neurosurg. 2017. PMID: 28512051. doi:10.1016/j.wneu.2017.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。